Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2016/0237099 AMINE SUBSTITUTED TRISILYLAMINE AND TRIDISILYLAMINE COMPOUNDS AND SYNTHESIS METHODS THEREOF
Halogen free amine substituted trisilylamine and tridisilylamine compounds and a method of their preparation via de-hydrogenative coupling between the...
2016/0237098 LITHIUM SECONDARY BATTERY, ELECTROLYTE SOLUTION FOR LITHIUM SECONDARY BATTERY, AND ADDITIVE FOR ELECTROLYTE...
Provided are a lithium secondary battery having improved initial capacity and excellent cycle property, an electrolyte solution for the lithium secondary...
2016/0237097 BORATES FOR PHOTOACTIVATED CHEMICAL BLEACHING
A borate compound for use as photoinduced chemical bleaching reagent is disclosed having improved bleaching performance under certain conditions, compared to...
2016/0237096 AZABENZIMIDAZOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS
A compound satisfying formula I, a prodrug, N-oxide, addition salt, quaternary amine, metal complex, or a stereochemically isomeric form thereof; ...
2016/0237095 RHO KINASE INHIBITORS
The invention provides novel inhibitors of ROCK1 and/or ROCK2. Also provided are methods of treating diseases and disorders involving inhibiting ROCK1 and/or...
2016/0237094 THERAPEUTIC COMPOUNDS AND USES THEREOF
Described herein are compounds of Formula (I)-(III), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Also provided are...
2016/0237093 THERAPEUTIC COMPOUNDS AND USES THEREOF
Described herein are compounds of Formula (I) or Formula (VI), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Also...
2016/0237092 PHARMACEUTICAL COMPOSITIONS COMPRISING PERILLYL ALCOHOL DERIVATIVES
A pharmaceutical composition is provided which includes perillyl alcohol conjugated with a therapeutic agent and further includes and a hydrolyzable acylated...
2016/0237091 INHIBITORS OF ERK AND METHODS OF USE
The present invention provides chemical entities or compounds and pharmaceutical compositions thereof that are capable of modulating certain protein kinases...
2016/0237090 NOVEL PYRAZINE COMPOUNDS FOR THE TREATMENT OF INFECTIOUS DISEASES
The present invention relates to compounds of the formula (I), ##STR00001## or pharmaceutically acceptable salts, enantiomer or diastereomer thereof, wherein...
2016/0237089 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF
Compounds, compositions and methods are described for inhibiting the TRPC5 ion channel and disorders related to TRPC5.
2016/0237088 TRICYCLIC OXAZOLIDINONE ANTIBIOTIC COMPOUNDS
The invention relates to compounds of formula I ##STR00001## wherein "" is a bond or is absent, V is CH, CR.sup.6 or N; R.sup.0 is H or, if "" is a bond, may...
2016/0237087 HETEROCYCLIC COMPOUNDS
A compound having an SSTR5 antagonist action and use of the compound as a medicament are provided. Specifically, a compound represented by the following...
2016/0237086 5-CHLORO-2-DIFLUOROMETHOXYPHENYL PYRAZOLOPYRIMIDINE COMPOUNDS,COMPOSITIONS AND METHODS OF USE THEREOF
Compounds of Formula (00A) and methods of use as Janus kinase inhibitors are described herein.
2016/0237085 CRYSTALLINE BROMODOMAIN INHIBITORS
N-[4-(2,4-difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c- ]pyridin-4-yl)phenyl]ethanesulfonamide and crystalline forms thereof are suitable...
2016/0237084 DIHYDRO-PYRROLOPYRIDINONE INHIBITORS
The present invention provides for compounds of formula (I) ##STR00001## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, and R.sup.5 have any of the values defined...
2016/0237083 INDOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS
Indoles having inhibitory activity on RSV replication and having the formula I ##STR00001## the prodrugs, N-oxides, addition salts, quaternary amines, metal ...
2016/0237082 DEUBIQUITINASE INHIBITORS AND METHODS FOR USE OF THE SAME
Disclosed herein are methods of inhibiting a deubiquitinase (DUB) by contact with a compound of formula (I) ##STR00001##
2016/0237081 TRIAZOLOPYRIDINE ETHER DERIVATIVES AND THEIR USE IN NEUROLOGICAL AND PYSCHIATRIC DISORDERS
The disclosure generally relates to compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds...
2016/0237080 PROCESS OF SYNTHESIZING 2-BROMO-LSD
A process of synthesizing 2-bromo-LSD or a salt or hydrate thereof comprising the steps of reacting methylergometrine with a brominating agent to produce...
2016/0237079 Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
The present invention relates to modulators of cystic fibrosis Transmembrane Conductance Regulator ("CFTR"), compositions thereof, and methods therewith. The...
2016/0237078 NOVEL 6-AMINO ACID HETEROARYLDIHYDROPYRIMIDINES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION
The invention provides novel compounds having the general formula: ##STR00001## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4 and A are as described herein, ...
2016/0237077 PROCESS FOR THE INDUSTRIAL SYNTHESIS OF LURASIDONE
Disclosed is a process for the industrial synthesis of Lurasidone from (1R,2R)-cyclohexane-1,2-diyldimethanol (1), 3-(piperazin-1-yl)benzo[d]isothiazole (3)...
2016/0237076 DEOXYCYTIDINE KINASE INHIBITORS
Provided herein are compounds that bind to dCK and methods for treating cancer.
2016/0237075 SUBSTITUTED NICOTINIMIDE INHIBITORS OF BTK AND THEIR PREPARATION AND USE IN THE TREATMENT OF CANCER,...
Compounds of Formula I, as shown below and defined herein: ##STR00001## and pharmaceutically acceptable salts, syntheses, intermediates, formulations, and...
2016/0237074 COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF DEGENERATIVE DISEASES AND DISORDERS
Disclosed are compounds or pharmaceutically acceptable salts thereof, having the structure of formula I. Also disclosed are methods of preventing and/or...
2016/0237073 Novel Polymorphs and Salts
The present invention is directed to novel polymorphs and salts of a compound which is an inhibitor of kinase activity.
2016/0237072 OXAZOLIDINONES AS MODULATORS OF MGLUR5
The disclosure generally relates to compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds...
2016/0237071 T-TYPE CALCIUM CHANNEL INHIBITOR
A novel compound that has an excellent T-type calcium channel inhibitory activity and is specifically useful for prevention or treatment of pain, chronic...
2016/0237070 1-(Arylmethyl)quinazoline-2,4(1H,3H)-Diones as PARP Inhibitors and the Use Thereof
Disclosed are 1-(arylmethyl)quinazoline-2,4(1H,3H)-diones represented by the Formula (I): ##STR00001## wherein Ar, R.sub.1-R.sub.6 are defined herein. ...
2016/0237069 INHIBITION OF OLIG2 ACTIVITY
Described herein are compounds and pharmaceutical compositions containing such compounds, which inhibit the activity of Olig2. Also described herein are...
2016/0237068 HYDROCHLORIDE SALT FORM FOR EZH2 INHIBITION
Provided herein are novel solid forms of N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(tetrahydr- ...
2016/0237067 SUBSTITUTED PHENYLALANINE DERIVATIVES
The invention relates to substituted phenylalanine derivatives and to processes for preparation thereof, and to the use thereof for production of medicaments...
2016/0237066 IMPROVED PROCESS FOR THE PREPARATION OF ...
The present invention relates to process for the preperation of (3S,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydr- ...
2016/0237065 OXAZETIDINE DERIVATIVES, PROCESS FOR PREPARING THEM AND USE IN HUMAN MEDICINE AND IN COSMETICS
Compounds that are agonists of the MCIR receptor and that exhibit reduced toxicity relative to other compounds of the same class are described. These compounds...
2016/0237064 THERAPEUTIC METHODS AND COMPOSITIONS INVOLVING ALLOSTERIC KINASE INHIBITION
The present invention is directed to methods and compositions for suppressing lymphangiogenesis, angiogenesis and/or tumor growth. The methods comprise...
2016/0237063 HINDERED AMINE LIGHT STABILIZERS
A compound of the formula (I), wherein R.sub.1 and R.sub.2 independently of one another are hydrogen, C.sub.1-C.sub.22alkyl, --O., --OH, --CH.sub.2CN,...
2016/0237062 Isoquinoline Compounds
Described herein are compounds of Formula (I) and tautomers and pharmaceutical salts thereof, compositions and formulations containing such compounds, and...
2016/0237061 ORGANIC COMPOUNDS
The invention relates to compounds and methods of treatment relating to nicotinic receptor antagonists. For example, the compounds and methods of treatment...
2016/0237060 3-HETEROAROYLAMINO-PROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS
The present invention relates to compounds of the formula I, ##STR00001## wherein Ht, G, R.sup.10, R.sup.30, R.sup.40, R.sup.50 and R.sup.60 have the meanings...
2016/0237059 HETEROCYCLIC SUBSTITUTED TRIFLUOROMETHYL PYRIMIDINONES AND THEIR USE
The present application relates to novel heterocyclically substituted 6-(trifluoromethyl)pyrimidin-4(3H)-one derivatives, to processes for their preparation,...
2016/0237058 PHENOXY THIOPHENE SULFONAMIDES AND OTHER COMPOUNDS FOR USE AS INHIBITORS OF BACTERIAL GLUCURONIDASE
This invention relates generally to compounds that are glucuronidase inhibitors. The glucuronidase inhibitors include phenoxy thiophene sulfonamides, and other...
2016/0237057 DIARYLALKYLAMINE REV-ERB ANTAGONISTS AND THEIR USE AS MEDICAMENTS
The present invention relates to compounds of Formula (I) or pharmaceutically acceptable salts or solvates thereof: It further discloses a pharmaceutical...
2016/0237056 NOVEL SYNTHESIS ROUTES FOR PROSTAGLANDINS AND PROSTAGLANDIN INTERMEDIATES USING METATHESIS
Methods of synthesizing prostaglandins, prostaglandin analogs and their synthetic intermediates are described. The methods can comprise metal-catalyzed...
2016/0237055 NOVEL SUBSTITUTED N, N-DIMETHYLAMINOALKYL ETHERS OF ISOFLAVANONE OXIMES AS H1-RECEPTOR ANTAGONISTS
The present invention relates to compounds of formula (I), and salts thereof and the pharmaceutical composition containing them in treatment of various...
2016/0237054 PROCESS FOR THE PURIFICATION OF DAPAGLIFLOZIN
The present invention provides a process for the preparation of (1C)-2,3,4,6-tetra-O-acetyl-1,5-anhydro-1-[4-chloro-3-(4-ethoxybenzyl)phe- nyl]-D-glucitol of...
2016/0237053 TRICYCLIC CONDENSED HETEROCYCLIC COMPOUND, METHOD FOR PRODUCING SAME, AND USE THEREOF
A compound derived from the culture product of an actinomycete and having an antitumor activity is provided. Provided is a compound represented by any one of...
2016/0237052 Histamine-3 Receptor Antagonists
The invention is directed to a compound of formula I, as defined herein, or a pharmaceutically acceptable salt thereof; a pharmaceutical composition containing...
2016/0237051 EPOXIDATION CATALYSTS BASED ON METAL ALKOXIDE PRETREATED SUPPORTS
The present disclosure generally relates to a silica-titanium catalyst prepared by first reacting a solid support with a metal alkoxide and then depositing...
2016/0237050 SYNTHESIS PROCESS FOR DIACETYL EPOXY GLYCERYL OLEATE
The present invention relates to a process for the synthesis of diacetyl epoxy glyceryl oleate, comprising the steps of: a). esterification of glycerol and...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.